# Phase 3 Study of KHK7580

> **NCT02549404** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 137 (actual)

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** KHK7580

## Key facts

- **NCT ID:** NCT02549404
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-28
- **Primary completion:** 2016-12-06
- **Final completion:** 2016-12-28
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549404, "Phase 3 Study of KHK7580". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02549404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*